Annual Total Assets
$163.13 M
+$104.83 M+179.81%
June 30, 2024
Summary
- As of February 7, 2025, RENB annual total assets is $163.13 million, with the most recent change of +$104.83 million (+179.81%) on June 30, 2024.
- During the last 3 years, RENB annual total assets has fallen by -$26.48 million (-13.96%).
- RENB annual total assets is now -13.96% below its all-time high of $189.61 million, reached on June 1, 2021.
Performance
RENB Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$121.83 M
-$41.30 M-25.32%
September 30, 2024
Summary
- As of February 7, 2025, RENB quarterly total assets is $121.83 million, with the most recent change of -$41.30 million (-25.32%) on September 30, 2024.
- Over the past year, RENB quarterly total assets has increased by +$64.27 million (+111.65%).
- RENB quarterly total assets is now -42.61% below its all-time high of $212.28 million, reached on March 31, 2024.
Performance
RENB Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
RENB Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +179.8% | +111.7% |
| 3 y3 years | -14.0% | +111.7% |
| 5 y5 years | -9.3% | +111.7% |
RENB Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.0% | +179.8% | -42.6% | +111.7% |
| 5 y | 5-year | -14.0% | +179.8% | -42.6% | +111.7% |
| alltime | all time | -14.0% | -100.0% | -42.6% | -100.0% |
Renovaro Biosciences Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $121.83 M(-25.3%) |
| Jun 2024 | $163.13 M(+179.8%) | $163.13 M(-23.2%) |
| Mar 2024 | - | $212.28 M(+265.9%) |
| Dec 2023 | - | $58.02 M(+0.8%) |
| Sep 2023 | - | $57.56 M(-1.3%) |
| Jun 2023 | $58.30 M(-31.1%) | - |
| Jun 2023 | - | $58.30 M(-25.9%) |
| Mar 2023 | - | $78.73 M(-1.9%) |
| Dec 2022 | - | $80.27 M(-3.4%) |
| Sep 2022 | - | $83.07 M(-1.8%) |
| Jun 2022 | $84.63 M(-55.4%) | $84.63 M(-53.0%) |
| Mar 2022 | - | $180.10 M(-1.7%) |
| Dec 2021 | - | $183.14 M(-0.5%) |
| Sep 2021 | - | $184.06 M(-2.9%) |
| Jun 2021 | $189.61 M(+6.5%) | $189.61 M(+9.2%) |
| Mar 2021 | - | $173.70 M(+0.5%) |
| Dec 2020 | - | $172.89 M(-1.3%) |
| Sep 2020 | - | $175.13 M(-1.7%) |
| Jun 2020 | $178.10 M(-1.0%) | $178.10 M(-1.3%) |
| Mar 2020 | - | $180.51 M(+1.2%) |
| Dec 2019 | - | $178.36 M(-1.3%) |
| Sep 2019 | - | $180.62 M(+0.4%) |
| Jun 2019 | $179.88 M(-1.4%) | $179.88 M(+6.2%) |
| Mar 2019 | - | $169.31 M(-2.7%) |
| Dec 2018 | - | $173.96 M(-1.0%) |
| Sep 2018 | - | $175.80 M(-3.7%) |
| Jun 2018 | $182.50 M | $182.50 M(+26.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $144.26 M(+1743.1%) |
| Dec 2017 | - | $7.83 M(+110.9%) |
| Sep 2017 | - | $3.71 M(-17.9%) |
| Jun 2017 | $4.52 M(+419.3%) | $4.52 M(+1082.9%) |
| Mar 2017 | - | $382.30 K(-11.3%) |
| Dec 2016 | - | $431.00 K(-54.4%) |
| Sep 2016 | - | $944.70 K(+8.5%) |
| Jun 2016 | $870.80 K(-58.0%) | $870.80 K(-11.2%) |
| Mar 2016 | - | $980.50 K(-26.6%) |
| Dec 2015 | - | $1.34 M(-22.8%) |
| Sep 2015 | - | $1.73 M(-52.5%) |
| Jun 2015 | $2.07 M(-60.4%) | - |
| Mar 2015 | - | $3.64 M(-30.5%) |
| Dec 2014 | $5.24 M(>+9900.0%) | $5.24 M(+105.3%) |
| Sep 2014 | - | $2.55 M(+255.3%) |
| Jun 2014 | - | $718.30 K(-21.2%) |
| Mar 2014 | - | $911.50 K(>+9900.0%) |
| Dec 2013 | - | $0.00(-100.0%) |
| Sep 2013 | - | $13.20 K(-1.5%) |
| Jun 2013 | - | $13.40 K(-33.0%) |
| Mar 2013 | $20.00 K(+47.1%) | $20.00 K(+49.3%) |
| Dec 2012 | - | $13.40 K(-13.5%) |
| Sep 2012 | - | $15.50 K(+14.0%) |
| Jun 2012 | - | $13.60 K(0.0%) |
| Mar 2012 | $13.60 K(>+9900.0%) | $13.60 K(+2.3%) |
| Dec 2011 | - | $13.30 K |
| Mar 2011 | $0.00 | - |
FAQ
- What is Renovaro Biosciences annual total assets?
- What is the all time high annual total assets for Renovaro Biosciences?
- What is Renovaro Biosciences annual total assets year-on-year change?
- What is Renovaro Biosciences quarterly total assets?
- What is the all time high quarterly total assets for Renovaro Biosciences?
- What is Renovaro Biosciences quarterly total assets year-on-year change?
What is Renovaro Biosciences annual total assets?
The current annual total assets of RENB is $163.13 M
What is the all time high annual total assets for Renovaro Biosciences?
Renovaro Biosciences all-time high annual total assets is $189.61 M
What is Renovaro Biosciences annual total assets year-on-year change?
Over the past year, RENB annual total assets has changed by +$104.83 M (+179.81%)
What is Renovaro Biosciences quarterly total assets?
The current quarterly total assets of RENB is $121.83 M
What is the all time high quarterly total assets for Renovaro Biosciences?
Renovaro Biosciences all-time high quarterly total assets is $212.28 M
What is Renovaro Biosciences quarterly total assets year-on-year change?
Over the past year, RENB quarterly total assets has changed by +$64.27 M (+111.65%)